New Report Biosimilars (2009 - 2014) Published By MarketsandMarkets
The increasing demand from patients, insurers
, and government agencies to reduce the costs of blockbuster biopharmaceuticals has created numerous opportunities in the global biosimilar market. Regulatory developments favoring the biosimilar market in countries such as the U.S. are expected to increase the market shares and profit margins of the market players.
The globalbiosimilarsmarket is expected to be worth $19.4 billion by 2014, growing at a CAGR of 89.1% from 2009 to 2014. The early commercialization and high absorption rate of biosimilars products have made Asia the dominant market in 2008 with 34.1% share of the globalbiosimilarsproduct market. Americas is the second-largest market and is expected to be dominate in 2014, after the U.S. market opens up in 2010.
The biosimilars market is highly fragmented with major market players such as Biocon, Dr. Reddy's Laboratories, Intas, LG LifeSciences, Ranbaxy, Reliance LifeSciences, Sandoz, Teva, and Wockhardt.
Scope of the report
This report aims to identify and analyze thebiosimilarsmarket on the basis of products, services, technologies, and applications. The report has segmented the global biosimilars market as follows:
Biosimilar products market - Peptides, recombinant glycosylated proteins, recombinant non-glycosylated proteins, and others
Biosimilar services market - Contract research and manufacturing services, clinical trial services
Biosimilar applications market - Oncology, infectious diseases, chronic and autoimmune diseases, and other diseases
Biosimilar technologies market - Recombinant DNA technology, monoclonal antibodies technologies, protein sequencing, bioassay, chromatography, nuclear magnetic resonance (NMR), and mass spectrometry
Each section provides market data, market drivers, trends and opportunities, top-selling products, key players, and competitive landscape. This report also provides more than 60 market tables for the biosimilar micro-markets in four main geographic regions, i.e. the Americas (North and South America), Europe, Asia, and ROW (includes all the countries not covered in the above categories). In addition, the report also provides 40 company profiles as part of the competitive landscape in the biosimilar market.
What makes our reports unique?
We provide the longest market segmentation chain in the industry with our three-level market breakdown and our analysis of minimum 40 collectively exhaustive and mutually exclusive micro markets.
We provide 10% customization to ensure that our clients find the specific market intelligence they need.
Each report is about 150 pages, featuring 30+ market data tables, 30+ company profiles, and an analysis of 200 patents.
No single report by any other publisher provides market data for all market segments (i.e. products, services, applications, ingredients, and technology) covering the four geographies of North America, Europe, Asia Pacific, and ROW.
15 pages of high level analysis identifying opportunities, best practices, entry strategies, benchmarking strategies, market positioning, product positioning, and competitive positioning.
Key questions answered
Which are the high-growth segments and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
What are market estimates and forecasts; which markets are doing well and which are not?
Where are the gaps and opportunities; what factors are driving market growth?
Which are the key playing fields and winning-edge imperatives?
What is the competitive landscape; who are the main players in each segment; what are their strategic directives, operational strengths, key selling products, and product pipelines? Who is doing what?
Powerful Research and analysis
The analysts working with MarketsandMarkets come from renowned publishers and market research firms globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies.
source:
Market Research ReportsNew Report Biosimilars (2009 - 2014) Published By MarketsandMarkets
By: Ms. Sunita
Do You Ask Scampish Questions? Set off a direct marketing buzz with Coulson Organisation Converting Your Marketing Leads Into Buyers Quickly Boost Sales By Using Targeted Marketing Strategy Bank Lending In Mortgage Market 'has Improved' How to Increase Traffic To Your Website Using Organic SEO Marketing Different Ways To Increase Profits Common Challenges In Cosmetic Dental Marketing Explored Four Ways to Find the Right Email Marketing Solution for Your Sales Team Leave The Burden Of Going To Market Share Market Tips Provider Marketing With Press Releases How To Know 3 Things All Affiliate Marketers Need To Survive Online